Back to Search
ELIZABETH YORK, DO
DO
Physical Medicine & Rehabilitation Physician
NPI: 1124581806IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
11901397-1204(UT)
Education
KANSAS CITY UNIVERSITY OF MED & BIOSCIENCES, COLLEGE OF OSTEO MED
Class of 2019
Research & Publications (16)
Effect of calorie restriction on subjective ratings of appetite.
PMID 19302119·J Hum Nutr Diet·2009
2-rct
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
PMID 18310480·Am J Respir Crit Care Med·2008
4-observational
Construct validation of two music-based assessments for people with dementia.
PMID 17997626·J Music Ther·2007
4-observational
A southern California freeway is a physical and social barrier to gene flow in carnivores.
PMID 16689893·Mol Ecol·2006
7-preclinical
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
PMID 16460562·BMC Pulm Med·2006
4-observational
Teaching evidence-based medicine to internal medicine residents: the efficacy of conferences versus small-group discussion.
PMID 15833722·Teach Learn Med·2005
4-observational
Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.
PMID 15878795·Peptides·2005
7-preclinical
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
PMID 15229100·Am J Respir Crit Care Med·2004
3-trial
Chemometric discrimination of unfractionated plant extracts analyzed by electrospray mass spectrometry.
PMID 12590113·Phytochemistry·2003
8-other
Bradykinin antagonists as new drugs for prostate cancer.
PMID 12489792·Int Immunopharmacol·2002
7-preclinical
Bradykinin-related compounds as new drugs for cancer and inflammation.
PMID 12025961·Can J Physiol Pharmacol·2002
7-preclinical
Genetic testing: the future of smoking cessation therapy?
PMID 11963809·Expert Rev Mol Diagn·2002
6-review
Metabolism-resistant bradykinin antagonists: development and applications.
PMID 11258669·Biol Chem·2001
6-review
An NMR conformational analysis of cyclic bradykinin mimics. Evidence for a beta-turn.
PMID 10949162·J Biomol Struct Dyn·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N 1900 E RM 1C301
SALT LAKE CITY, UT 84132 - Phone
- (801) 581-7985
Quick Facts
- NPI
- 1124581806
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 16
Are you this provider?
Claim Your Profile